Upexi, Inc. (UPXI) — 10-Q Filings

All 10-Q filings from Upexi, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

  • UPEXI Swings to $66.7M Profit on Solana Bet, Digital Assets Soar — Nov 12, 2025 Risk: high
    UPEXI, INC. reported a significant financial turnaround for the three months ended September 30, 2025, achieving a net income of $66,748,122, a substantial impr
  • UPEXI, INC. Files Q2 2025 10-Q — Feb 14, 2025 Risk: low
    UPEXI, INC. filed its 10-Q for the period ending December 31, 2024. The company, formerly known as GROVE, INC., is in the medicinal chemicals & botanical produc
  • UPEXI, INC. Files Q1 2025 10-Q — Dec 19, 2024 Risk: low
    UPEXI, INC. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as GROVE, INC., is in the medicinal chemicals & botanical produ
  • UPEXI, INC. Files 10-Q for Q3 2024 — Jul 9, 2024 Risk: low
    UPEXI, INC. filed a 10-Q for the period ending March 31, 2024. The company, formerly known as GROVE, INC., is incorporated in Nevada and operates in the medicin
  • UPEXI, INC. Files 10-Q for Period Ending December 31, 2023 — Feb 14, 2024 Risk: medium
    UPEXI, INC. (UPXI) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. UPEXI, INC. reported financial results for the period ending December 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.